Immunological enhancement of primary tumor development and its prevention

被引:27
作者
Schreiber, H
Wu, TH
Nachman, J
Rowley, DA
机构
[1] Univ Chicago, Dept Pathol, Chicago, IL USA
[2] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA
关键词
T cells; antibody; tumor promotion;
D O I
10.1006/scbi.2000.0331
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
While it has been known for decades that the growth of tumor transplants can be enhanced immunologically, the potential significance of these previous findings to the development of primary tumors and the mechanisms of tumor enhancement has remained obscure. This review will summarize recent experiments indicating that primary turner development, can De enhanced by active immunization. The evidence suggests that antibodies, B cells and CD4(+) T cells can play a critical role in enhancing the development of primary tumors, whereas endogenous interferon-gamma (IFN gamma) can counteract enhancement. Thus, we envision two possible functions of IFN gamma: (i) preventing B cell and antibody enhancement and (ii) counteracting tumor promotion independent of T and B cells.
引用
收藏
页码:351 / 357
页数:7
相关论文
共 66 条
  • [1] [Anonymous], 1999, INFLAMMATION BASIC P
  • [3] Baselga J, 1999, SEMIN ONCOL, V26, P78
  • [4] Expression of interferon-β is associated with growth arrest of murine and human epidermal cells
    Bielenberg, DR
    McCarty, MF
    Bucana, CD
    Yuspa, SH
    Morgan, D
    Arbeit, JM
    Ellis, LM
    Cleary, KR
    Fidler, IJ
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (05) : 802 - 809
  • [5] BRODT P, 1982, CANCER IMMUNOL IMMUN, V13, P125
  • [6] Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells
    Coffey, RJ
    Hawkey, CJ
    Damstrup, L
    GravesDeal, R
    Daniel, VC
    Dempsey, PJ
    Chinery, R
    Kirkland, SC
    DuBois, RN
    Jetton, TL
    Morrow, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (02) : 657 - 662
  • [7] Tumor cell responses to IFNγ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis
    Coughlin, CM
    Salhany, KE
    Gee, MS
    LaTemple, DC
    Kotenko, S
    Ma, XJ
    Gri, G
    Wysocka, M
    Kim, JE
    Liu, L
    Liao, F
    Farber, JM
    Pestka, S
    Trinchieri, G
    Lee, WMF
    [J]. IMMUNITY, 1998, 9 (01) : 25 - 34
  • [8] SERUM AND GLUCOCORTICOID REGULATION OF GENE-TRANSCRIPTION AND EXPRESSION OF THE PROSTAGLANDIN-H SYNTHASE-1 AND PROSTAGLANDIN-H SYNTHASE-2 ISOZYMES
    DEWITT, DL
    MEADE, EA
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 306 (01) : 94 - 102
  • [9] ENHANCED IN-VIVO GROWTH AND RESISTANCE TO REJECTION OF TUMOR-CELLS EXPRESSING DOMINANT-NEGATIVE IFN-GAMMA RECEPTORS
    DIGHE, AS
    RICHARDS, E
    OLD, LJ
    SCHREIBER, RD
    [J]. IMMUNITY, 1994, 1 (06) : 447 - 456
  • [10] INHIBITION OF TUMOR-GROWTH BY A MONOCLONAL-ANTIBODY REACTIVE WITH AN ONCOGENE-ENCODED TUMOR-ANTIGEN
    DREBIN, JA
    LINK, VC
    WEINBERG, RA
    GREENE, MI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (23) : 9129 - 9133